The Drug Enterprise in the Age of AI
AI is speeding up the search for new medicines. Can it make the discoveries themselves? Few people are better placed to answer than Dr. Elias Zerhouni. He ran the National Institutes of Health, then global R&D at Sanofi. He co-founded ModeX Therapeutics, which uses machine learning to design antibodies that don’t exist in nature, and he is now vice chairman and president of its parent company, OPKO Health. His test for AI: give it every…
